Kiadis Pharma N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
06 may 2020 - 08:00
Statutory name
Kiadis Pharma N.V.
Title
Kiadis Pharma announces U.S. FDA approval to start NK-REALM Phase 2 clinical trial for natural killer (NK) cell therapy produced with PM21
Related downloads
Date last update: 10 July 2025